Rspo3 Antibody

What is RSPO3 and what are its primary functions in cellular signaling?

RSPO3 (R-spondin 3) is a member of the R-spondin family that plays crucial roles in regulating Wnt/β-catenin and Wnt/planar cell polarity (PCP) signaling pathways. These pathways are fundamentally involved in development, cell growth, and disease pathogenesis. RSPO3 specifically contributes to embryonic vasculogenesis and angiogenesis by regulating the balance between angioblast and blood cell specification, and may be involved in tumor development processes . Recent research has also established RSPO3's role in metabolic liver zonation and maintaining systemic glucose metabolism . Expression analysis shows that while RSPO3 is ubiquitously expressed, it demonstrates higher expression levels in placenta, small intestine, fetal thymus, and lymph node, with particularly robust expression in endothelial cells .

RSPO3 functions by engaging with heparan sulfate proteoglycans through its thrombospondin (TSP/BR) domain, which contains positively charged grooves that interact with heparan sulfate chains . This interaction appears to potentiate RSPO3's signaling activity, potentially by facilitating its presentation to receptor complexes or enhancing its stability in the extracellular matrix.

What molecular characteristics should researchers be aware of when selecting RSPO3 antibodies?

When selecting RSPO3 antibodies for research applications, several key molecular characteristics warrant careful consideration to ensure experimental success. First, researchers should note the significant discrepancy between calculated and observed molecular weights. RSPO3's calculated molecular weight is approximately 31 kDa, but it typically appears at 40-68 kDa in Western blots due to post-translational modifications .

Additionally, at least three isoforms of RSPO3 are known to exist, which may affect antibody selection depending on research goals . Some antibodies, like the Boster Bio Anti-R-spondin-3 (A05387), are designed to detect all three isoforms, making them suitable for comprehensive studies . The immunogen information is also critical - for example, the Boster antibody was raised against a 19 amino acid peptide near the carboxy terminus of human RSPO3, located within amino acids 200-250 .

Understanding these characteristics helps researchers select the most appropriate antibody for their specific experimental system and research questions.

What are the optimal protocols for RSPO3 detection in Western blot experiments?

Successful Western blot detection of RSPO3 requires careful optimization of multiple experimental parameters. Based on validated antibody applications, the following protocol elements are recommended for robust RSPO3 detection:

For sample preparation, standard cell lysis using RIPA buffer supplemented with protease inhibitors works effectively for most cell types. When using the Boster Bio RSPO3 antibody (A05387), the recommended working concentration is 1-2 μg/mL for Western blot applications . This antibody has been successfully validated in human samples, specifically 293 cell lysates, detecting a band at approximately 68 kDa .

A typical Western blot protocol should include:

• Loading 20-50 μg of total protein per lane on a 10-12% SDS-PAGE gel

• Transferring to PVDF or nitrocellulose membrane (PVDF may provide better results for hydrophobic proteins)

• Blocking with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Incubating with primary antibody diluted in blocking buffer overnight at 4°C

• Washing thoroughly with TBST (at least 3 × 10 minutes)

• Incubating with appropriate HRP-conjugated secondary antibody

• Developing using ECL or similar chemiluminescence reagents

When interpreting results, researchers should be prepared to observe RSPO3 at a higher molecular weight than calculated (40-68 kDa versus the calculated 31 kDa) . This discrepancy is likely due to post-translational modifications such as glycosylation. If multiple bands are observed, they may represent different isoforms or differently modified forms of RSPO3.

How can immunofluorescence techniques be optimized for visualizing RSPO3 distribution in tissues?

Immunofluorescence (IF) provides valuable insights into RSPO3's spatial distribution within tissues and cells. To optimize RSPO3 visualization using IF, several technical considerations should be addressed.

The search results reveal that RSPO3 exhibits a distinctive zonated expression pattern in liver tissue, with preferential localization in the pericentral zone . This spatial specificity requires careful tissue preparation and imaging approaches. For the Boster Bio RSPO3 antibody (A05387), a recommended starting concentration of 20 μg/mL has been validated for immunofluorescence applications in human cell samples .

A methodologically robust IF protocol for RSPO3 detection includes:

• Fixation with 4% paraformaldehyde for 15-20 minutes (critical for preserving antigen integrity)

• Permeabilization with 0.1-0.5% Triton X-100 for 5-10 minutes (gentle permeabilization preserves tissue architecture)

• Blocking with 5-10% normal serum (from the species in which the secondary antibody was raised)

• Primary antibody incubation overnight at 4°C at the recommended dilution

• Multiple washing steps with PBS (at least 3 × 5 minutes)

• Incubation with fluorophore-conjugated secondary antibody

• Nuclear counterstaining with DAPI

• Mounting with anti-fade medium to preserve fluorescence

For tissue-specific investigations, co-staining with cell-type markers can provide contextual information about RSPO3-expressing cells. The search results demonstrate successful co-staining of RSPO3 with markers such as HNF4α (hepatocyte nuclear factor), CD31 (endothelial marker), and CK19 (biliary epithelial marker) . When analyzing pericentral liver expression, the intensity of RSPO3 immunofluorescence can be measured along lines extending 20 μm from hepatic central veins .

What techniques can complement antibody-based approaches for RSPO3 detection and validation?

While antibody-based methods form the foundation of RSPO3 protein detection, complementary techniques can provide additional validation and overcome potential limitations of antibody specificity or sensitivity. These approaches are particularly valuable when establishing new experimental systems or validating antibody performance.

RNA-Scope analysis offers a powerful complementary approach for RSPO3 detection. This technique enables visualization of RSPO3 mRNA at the single-cell level with high specificity. The search results indicate successful application of RNA-Scope with specific RSPO3 probes in liver tissue sections, revealing dots of positive signals that can be quantitatively analyzed . This approach provides validation of expression patterns observed with antibody staining and can help resolve concerns about antibody specificity.

For functional validation, adenoviral-mediated expression of RSPO3 can serve as both a positive control and an experimental tool. As demonstrated in the search results, administration of Rspo3 adenovirus to mice increased hepatic RSPO3 expression at both mRNA and protein levels, which was confirmed by immunoblotting with anti-RSPO3 antibodies . This approach not only validates antibody specificity but also enables investigation of RSPO3's functional effects on downstream pathways.

Additionally, biochemical approaches targeting RSPO3's interaction partners can provide indirect validation. The search results describe experiments where researchers engineered a synthetic RSPO3 protein by replacing its TSP/BR domain with an scFv antibody (HS20) that binds heparan sulfate . Such domain replacement studies can elucidate the functional significance of specific protein regions while also providing controls for antibody validation.

How can RSPO3 antibodies be used to investigate metabolic liver zonation?

RSPO3 antibodies serve as essential tools for investigating the relationship between RSPO3 and metabolic liver zonation. The search results provide compelling evidence that RSPO3 displays a distinct zonated expression pattern in the liver, with predominant localization in the pericentral zone . This spatial regulation suggests a specialized role in liver metabolism that can be further explored using antibody-based techniques.

Immunofluorescence analysis with RSPO3 antibodies enables precise mapping of expression domains within the liver architecture. The data indicates that researchers have successfully visualized RSPO3 near hepatic central veins, where its expression can be co-analyzed with zone-specific markers like HNF4α . This co-localization analysis helps establish the relationship between RSPO3 expression and specific hepatic zones responsible for different metabolic functions.

Quantitative approaches using RSPO3 antibodies can measure expression gradients across the liver lobule. The research demonstrates that RSPO3 immunofluorescence intensity can be systematically measured along lines extending 20 μm from hepatic central veins . This quantitative spatial analysis enables correlation of RSPO3 expression levels with metabolic zonation patterns and functional outcomes.

Functional investigations combining RSPO3 antibodies with metabolic analyses reveal causal relationships. When Rspo3 adenovirus was administered to ob/ob mice, researchers observed effects on fasting blood glucose, insulin levels, and expression of key metabolic enzymes like PEPCK and GK . Confirmation of increased RSPO3 expression using antibody detection was essential to establish the link between RSPO3 levels and these metabolic parameters.

What approaches can researchers use to study RSPO3's interactions with heparan sulfate proteoglycans?

Investigating RSPO3's interactions with heparan sulfate proteoglycans (HSPGs) requires specialized experimental approaches that can reveal both physical interactions and functional consequences. The search results identify the thrombospondin (TSP/BR) domain of RSPO3 as containing positively charged grooves that interact with heparan sulfate chains .

Structural analysis combined with site-directed mutagenesis provides insights into interaction domains. The research describes K/R→E mutations in the TSP/BR domain that disrupted the interaction with HS chains . These mutations can be used as negative controls in antibody-based experiments to confirm specificity of detected interactions. When performing co-immunoprecipitation or proximity ligation assays with RSPO3 antibodies, including these mutants can differentiate specific from non-specific interactions.

Domain replacement studies offer functional validation of HSPG binding. Researchers engineered a synthetic RSPO3 protein in which they replaced the entire TSP/BR domain with HS20, an scFv antibody that binds heparan sulfate . This creative approach demonstrates that the HSPG-binding functionality can be provided through a structurally distinct domain, confirming the functional importance of this interaction.

Immunofluorescence co-localization experiments can visualize RSPO3-HSPG interactions in situ. Using RSPO3 antibodies in combination with antibodies or probes for HSPGs enables identification of potential interaction sites within tissues. This approach is particularly valuable for examining whether RSPO3-HSPG interactions show tissue-specific or context-dependent patterns.

Binding assays using purified components provide quantitative interaction data. While not explicitly described in the search results, solid-phase binding assays using recombinant RSPO3 and immobilized heparan sulfate can measure binding affinity and specificity. These assays can be enhanced by using antibodies to detect bound RSPO3, allowing for comparison of wild-type versus mutant binding properties.

How do physiological and pathological conditions affect RSPO3 expression patterns?

Understanding how RSPO3 expression changes under different physiological and pathological conditions provides insights into its regulatory mechanisms and potential therapeutic targeting. The search results reveal dynamic regulation of RSPO3 in response to metabolic conditions and disease states.

Nutritional status significantly impacts RSPO3 expression. Researchers examined serum RSPO3 levels and hepatic RSPO3 mRNA expression under both fasted and fed conditions in lean and ob/ob mice . This experimental design reveals how RSPO3 responds to acute metabolic changes, with antibody-based detection methods enabling quantification of these changes at the protein level.

Obesity models show altered RSPO3 expression profiles. The studies compared RSPO3 mRNA expression across lean, diet-induced obese (DIO), and ob/ob mice in various organs . While specific numerical data isn't provided in the excerpts, the experimental design suggests significant differences were observed across these metabolic phenotypes. Antibody-based techniques would be essential for confirming whether these transcriptional changes translate to protein level differences.

Tissue-specific regulation patterns provide insight into RSPO3's diverse functions. The research demonstrates that RSPO3 expression varies across tissues, with immunofluorescence analysis revealing concentrated expression in the pericentral zone of the liver . This zonated expression pattern suggests specialized regulatory mechanisms that may respond differently to systemic metabolic signals.

Experimental manipulation of RSPO3 affects metabolic parameters. When Rspo3 adenovirus was administered to ob/ob mice, it affected fasting blood glucose and insulin levels, as well as the expression of key metabolic enzymes . These findings suggest that RSPO3 not only responds to metabolic conditions but actively participates in their regulation, highlighting its potential importance in metabolic disorders.

Signaling pathway alterations occur downstream of RSPO3 modulation. The research shows that Rspo3 adenovirus administration affected insulin-stimulated serine473 phosphorylation of Akt protein in the liver . This observation connects RSPO3 expression changes to specific molecular signaling events, providing mechanistic insight into how RSPO3 might influence cellular responses in different physiological states.

How should researchers address molecular weight discrepancies when detecting RSPO3?

The significant discrepancy between RSPO3's calculated molecular weight (approximately 31 kDa) and its observed weights in Western blots (40-68 kDa) represents a common technical challenge . This difference requires careful consideration for accurate data interpretation and experimental design.

Post-translational modifications likely explain the higher observed molecular weight. RSPO3 contains potential glycosylation sites, and these modifications can substantially increase the apparent molecular weight on SDS-PAGE. Researchers can confirm this explanation through deglycosylation experiments, treating samples with enzymes like PNGase F before Western blotting. A significant shift to lower molecular weight after such treatment would confirm glycosylation as the primary cause of the discrepancy.

Multiple isoforms contribute to detection complexity. The search results indicate that "at least three isoforms of RSPO3 are known to exist," and some antibodies (like Boster's A05387) are designed to detect all three . When interpreting Western blot results, researchers should consider that multiple bands may represent different isoforms rather than non-specific binding. Carefully selecting positive controls that express known isoforms can help distinguish between these possibilities.

Experimental validation strategies can address molecular weight concerns:

• Include recombinant RSPO3 protein as a reference standard when available

• Run both reduced and non-reduced samples to assess the impact of disulfide bonds

• Use gradient gels for better resolution of higher molecular weight forms

• Compare results across multiple antibodies targeting different epitopes

When reporting results, researchers should explicitly acknowledge the molecular weight discrepancy and provide both the expected and observed weights. This transparency is essential for result reproducibility and proper interpretation by the scientific community. The consistent reporting of higher-than-calculated weights across different antibodies and studies suggests this is a genuine characteristic of RSPO3 rather than an artifact.

What strategies help ensure reproducible results when working with RSPO3 antibodies across different experimental systems?

Achieving reproducible results with RSPO3 antibodies across different experimental systems requires systematic approaches to validation and standardization. Several key strategies can enhance reliability:

Comprehensive antibody validation should be performed in each experimental system. The search results show that manufacturers validate antibodies across multiple applications (WB, ICC, IF) with specific cell types like 293 cells . Researchers should conduct their own validation in their specific experimental systems, especially when using tissues or cell types that differ from those used in manufacturer validation.

Multiple detection techniques provide cross-validation. As demonstrated in the research, combining protein detection (immunoblotting, immunofluorescence) with mRNA analysis (RNA-Scope) offers complementary evidence of RSPO3 expression patterns . Convergent results across these methods strengthen confidence in antibody specificity and detection accuracy.

Controls must be carefully selected based on known RSPO3 biology. The zonated expression of RSPO3 in liver means that whole liver lysates will show different results compared to zone-specific analyses . Similarly, the observed differences in expression between metabolic states (fasted vs. fed) and disease models (lean vs. obese) highlight the importance of appropriate positive and negative controls that match the experimental context .

Standardized protocols reduce technical variability:

• Sample collection timing should account for circadian or feeding-dependent expression changes

• Consistent fixation and antigen retrieval methods are critical for comparable immunostaining

• Identical blocking conditions help minimize background differences between experiments

• Image acquisition settings should be standardized for comparative analyses

Quantitative approach standardization enables meaningful comparisons across experiments. The research demonstrates specific quantification strategies, such as measuring immunofluorescence intensity along 20 μm lines from central veins or counting RNA-Scope positive dots . Adopting consistent quantification methods like these increases reproducibility and facilitates data comparison across studies.

Batch effects should be minimized through experimental design. Processing samples from different experimental groups simultaneously, using the same antibody lots, and including internal reference standards can reduce systematic biases. When reporting results, detailed methodological documentation enables others to reproduce the work accurately.

How can RSPO3 antibodies contribute to understanding the relationship between RSPO3 and systemic metabolism?

Recent research has unveiled RSPO3's significant role in metabolic regulation, opening new avenues for investigation using antibody-based approaches. The search results explicitly state that "modulation of hepatic Rspo3 contributes to maintaining systemic glucose metabolism and body composition" , highlighting the broader metabolic implications of RSPO3 beyond its developmental functions.

Tissue-specific metabolic effects can be mapped using immunohistochemical approaches. The zonated expression of RSPO3 in liver, particularly in the pericentral region , suggests specialized metabolic functions that can be investigated by correlating RSPO3 expression patterns with metabolic enzyme distributions. Using RSPO3 antibodies in multi-label immunofluorescence studies enables identification of metabolic zones and their alterations in disease states.

Comparative expression analyses across metabolic states provide mechanistic insights. The research examined RSPO3 levels under fasted versus fed conditions and in lean versus obese (ob/ob) mice . Extending this approach using quantitative Western blotting with RSPO3 antibodies would allow researchers to establish precise relationships between RSPO3 protein levels and metabolic parameters across diverse physiological and pathological conditions.

Experimental manipulation coupled with metabolic phenotyping offers causal evidence. The adenovirus-mediated RSPO3 expression in ob/ob mice affected fasting blood glucose, insulin levels, and expression of key metabolic enzymes like PEPCK and GK . This experimental paradigm could be expanded to investigate how RSPO3 modulation affects additional metabolic parameters such as lipid metabolism, insulin sensitivity, and energy expenditure, with antibody detection confirming successful manipulation.

Signaling pathway integration reveals molecular mechanisms. The research demonstrated that RSPO3 overexpression affected insulin-stimulated Akt phosphorylation , connecting RSPO3 to insulin signaling. RSPO3 antibodies can help dissect these signaling connections through co-immunoprecipitation studies, phospho-specific Western blots, and proximity ligation assays that visualize protein-protein interactions in situ.

What novel applications of RSPO3 antibodies are emerging in cancer and developmental biology research?

While the search results focus primarily on RSPO3's metabolic functions, they also reference its roles in development and tumor biology, suggesting important applications for RSPO3 antibodies in these research areas.

Cancer biology applications stem from RSPO3's potential involvement in tumor development . RSPO3 antibodies can be used to:

• Profile RSPO3 expression across tumor types and stages using tissue microarrays

• Correlate expression patterns with clinical outcomes and treatment responses

• Investigate RSPO3's interactions with tumor microenvironment components

• Explore its role in cancer stem cell maintenance through co-staining with stemness markers

The search results mention RSPO3's role in angioblast and blood cell specification during embryonic vasculogenesis and angiogenesis , highlighting applications in developmental biology. Researchers can use RSPO3 antibodies to:

• Map spatial and temporal expression patterns during embryonic development

• Trace lineage relationships between RSPO3-expressing cells and mature vascular structures

• Investigate RSPO3's role in tissue regeneration and wound healing models

• Explore its functions in stem cell differentiation protocols for regenerative medicine

RSPO3's interaction with heparan sulfate proteoglycans opens applications in extracellular matrix biology. RSPO3 antibodies can help elucidate how the extracellular matrix composition influences RSPO3 distribution and function across tissues, potentially explaining tissue-specific responses to RSPO3 signaling.

Technological innovations are expanding antibody applications. Beyond traditional Western blotting and immunostaining, RSPO3 antibodies can be incorporated into:

• High-content imaging systems for automated quantification of expression patterns

• Mass cytometry (CyTOF) for single-cell protein profiling in heterogeneous populations

• Multiplex immunofluorescence panels to simultaneously visualize multiple pathway components

• Intravital imaging approaches to monitor RSPO3 dynamics in living organisms